JTJ. Peter van Tintelen

J. Peter van Tintelen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. Peter van Tintelen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lamin A/C-Related Cardiac Disease and Pregnancy

    by J. Peter van Tintelen, Karin Y. van Spaendonck-Zwarts, Maarten P. van Den Berg


  • Recurrent and founder mutations in the Netherlands

    by J. J. J. Aalberts, A. G. Schuurman, G. Pals, B. J. C. Hamel, G. Bosman, Y. Hilhorst-Hofstee, D. Q. C. M. Barge-Schaapveld, B. J. M. Mulder, M. P. van Den Berg, J. P. van Tintelen

    Background/Methods. Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MFS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome’s manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large fourgeneration Dutch family with MFS. Results. Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinical variability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time. Conclusion. MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85–9.)


  • Recurrent and founder mutations in inherited cardiac diseases in the Netherlands

    by J. P. van Tintelen, A. A. M. Wilde, J. D. H. Jongbloed


  • Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene

    by J. Peter van Tintelen, Isabelle C. Van Gelder, Angeliki Asimaki, Albert J.H. Suurmeijer, Ans C.P. Wiesfeld, Jan D.H. Jongbloed, Arthur van Den Wijngaard, Jan B.M. Kuks, Karin Y. van Spaendonck-Zwarts, Nicolette Notermans, et al.


  • The many faces of aggressive aortic pathology: Loeys-Dietz syndrome

    by J. J. J. Aalberts, M. P. van Den Berg, J. E. H. Bergman, G. J. du Marchie Sarvaas, J. G. Post, H. van Unen, G. Pals, P. W. Boonstra, J. P. van Tintelen

    Background: Loeys-Dietz syndrome (LDS) is a newly recognised disorder of connective tissue which shares overlapping features with Marfan syndrome (MFS) and the vascular type of Ehlers- Danlos syndrome, including aortic root dilatation and skin abnormalities. It is clinically classified into types 1 and 2. LDS type 1 can be recognised by craniofacial characteristics, e.g. hypertelorism, bifid uvula or cleft palate, whereas these are absent in LDS type 2. It is important to recognise LDS because its vascular pathology is aggressive. We describe nine LDS patients from four families, relate their features to published cases, and discuss important aspects of the diagnosis and management of LDS in order to make clinicians aware of this new syndrome. Results: Characteristics found in the majority of these LDS patients were aortic root dilatation, cleft palate and/or a bifid/abnormal uvula. Conclusion: Because aortic dissection and rupture in LDS tend to occur at a young age or at aortic root diameters not considered at risk in MFS, and because the vascular pathology can be seen throughout the entire arterial tree, patients should be carefully followed up and aggressive surgical treatment is mandatory. Clinicians must therefore be aware of LDS as a cause of aggressive aortic pathology and that its distinguishing features can sometimes be easily recognised. (Neth Heart J 2008;16:299-304.)